Discover research programs and initiatives that seek to inform prevention, diagnosis, and treatment for today’s major health challenges and conditions.
NHLBI-supported research has contributed to heart failure treatments using breakthrough therapies.
BioData Catalyst is a cloud-based ecosystem with data and analytic capabilities to advance research on heart, lung, blood, and sleep diseases, disorders, and conditions.
CEAL is helping communities hardest hit by COVID-19. Learn more about CEAL and its programs.
Asthma is a long-term condition in which the airways become inflamed and narrowed at times. This makes it hard to breathe.
Heart-healthy living can prevent and treat heart disease. It includes choosing healthy foods, getting more physical activity, aiming for a healthy weight, managing stress, quitting smoking, and getting enough good-quality sleep.
Coronary heart disease is a common type of heart disease where the arteries of the heart cannot deliver enough oxygen-rich blood to the heart.
Cardiac arrest is a life-threatening condition in which the heart suddenly stops beating.
A heart attack, also known as myocardial infarction, happens when the flow of blood that brings oxygen to your heart suddenly becomes blocked and your heart can’t get enough oxygen.
Sickle cell disease causes the red blood cells to have a sickle or crescent shape instead of a disc shape. The sickle-shaped cells can block blood vessels and lead to serious health problems.
The NHLBI has materials for patients and health professionals on many health topics, such as asthma, heart disease, and sickle cell disease.
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives.